Stress and mood of adults with moyamoya disease: A cross‐sectional study

Abstract

Moyamoya disease in adults is a chronic, progressive disorder characterized by fine collateral vessel networks in the brain. The disorder can lead to negative mood and stress, which, left unresolved, may increase adverse health outcomes. We conducted a cross‐sectional survey to examine stress and mood of adults with moyamoya disease. Participants were recruited at a university hospital in Seoul, Korea. Data were collected through questionnaires and review of participants' electronic medical records. A total of 109 adults participated. Significant correlations were found between perceived stress, anxiety, and depression. Adults with moyamoya disease experience anxiety, depression, and stress related to the risk of cerebral hemorrhage or ischemia, similar to those with other cerebrovascular disease. If negative mood and stress were uncontrolled, those can cuase adverse health outcomes. Health professionals caring for people with moyamoya disease should carefully observe their stress and mood and develop interventions tailored to stages of disease to help them manage. The study results provide baseline information for understanding the level of, and the factors associated with, stress and mood.

Psychometric Properties of the Korean Version of the PsyMate Scale Using a Smartphone App: Ecological Momentary Assessment Study

“…This finding is in accordance with the results of a study on the Dutch version of the PsyMate, which presented sensitivity to the change of mood over time and applicability for patients in an ambulatory mental health setting in the Netherlands [ 25 ]. The poor ICCs may reflect the dynamics of affect fluctuating and changing over time [ 41 ] and the variability in the anxious and depressive mood of patients with MMD [ 7 , 42 ].…”

Atrophy in subcortical gray matter in adult patients with moyamoya disease

“…A systematic review [14] showed that the incidence rate of cognitive impairment in MMD was approximately 30%, with moderate to severe disturbance across varied cognitive domains. Although psychiatric changes are usually not onset symptoms, recent cross-sectional studies [15,16] found that depression, anxiety, and posttraumatic stress syndrome were common complications in MMD survivors and were correlated with neurological impairment [15]. Hippocampus atrophy is regarded as an imaging hallmark of dementia and is seen in a variety of neurodegenerative diseases and poststroke dementia patients [17].…”